Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland

References

• National Records of Scotland. Statistics and data: mid-year population estimates [Internet]. National Records of Scotland. 2017. [cited 2018 Feb 28]. Available at: https://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/population/population-estimates/mid-year-population-estimates.
   Google Scholar
• Alonso A, Logroscino G, Jick SS, Hernán MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745–51.
   PubMed Web of Science ®Google Scholar
• Black HA, Leighton DJ, Cleary EM, Rose E, Stephenson L, Colville S, et al. Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiol Aging. 2017;51:178.e11–178.e20.
   Web of Science ®Google Scholar
• The Scottish Motor Neuron Disease Research Group. The Scottish motor neuron disease register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992;55:536–41.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol. 2007;254:866–9.
   PubMed Web of Science ®Google Scholar
• Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP. Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish motor neuron disease register. J Neurol Neurosurg Psychiatry. 1996;60:147–51.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Swingler RJ. Scottish ALS/MND register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing. 2004;33:131–4.
   PubMed Web of Science ®Google Scholar
• Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish motor neuron disease register. J Neurol. 1993;240:339–46.
   PubMed Web of Science ®Google Scholar
• Quality Improvement Scotland. Neurological Health Services: Clinical Standards October 2009 [Internet]. 2009. Available at: http://www.scottishneurological.org.uk/content/res/final_qis_standards.pdf. Accessed February 6, 2018.
   Google Scholar
• Health Improvement Scotland. Neurological health services in Scotland: Final Report [Internet]. 2012. Available at: http://www.healthcareimprovementscotland.org/our_work/long_term_conditions/neurological_health_services/neuro_services_national_report.aspx. Accessed February 6, 2018.
   Google Scholar
• Swingler R. An audit of the health of people with motor neurone disease in Scotland: the Scottish motor neurone disease audit, research and trials (SMART) study. Unpublished. 2015.
   Google Scholar
• Ferrie J, Robertson PR, Watson N. Living with MND: an evaluation of care pathways available to adults with, and the families or carers of, adults with motor neurone disease in Scotland [Internet]. 2013. Available at: https://www.euanmacdonaldcentre.com/wp-content/uploads/2015/02/Living-with-MND_Jo-Ferrie_report.pdf. Accessed March 1, 2015
   Google Scholar
• Hardiman O, Al-Chalabi A, Brayne C, Beghi E, Van Den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557–63.
   PubMed Web of Science ®Google Scholar
• Edgren G, Hjalgrim H, Rostgaard K, Lambert P, Wikman A, Norda R, et al. Transmission of neurodegenerative disorders through blood transfusion. Ann Intern Med. 2016;165:316.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Sheng L, Shang H. Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Front Degener. 2013;14:241–5.
   PubMed Web of Science ®Google Scholar
• Seelen M, van Doormaal PTC, Visser AE, Huisman MHB, Roozekrans MHJ, de Jong SW, et al. Prior medical conditions and the risk of amyotrophic lateral sclerosis. J Neurol. 2014;261:1949–56.
   PubMed Web of Science ®Google Scholar
• Belbasis L, Bellou V, Evangelou E. Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology. 2016;46:96–105.
   PubMed Web of Science ®Google Scholar
• Malek AM, Barchowsky A, Bowser R, Youk A, Talbott EO. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res. 2012;117:112–9.
   PubMed Web of Science ®Google Scholar
• Sutedja NA, Veldink JH, Fischer K, Kromhout H, Heederik D, Huisman MHB, et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler. 2009;10:302–9.
   PubMed Web of Science ®Google Scholar
• Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181–93.
   PubMed Web of Science ®Google Scholar
• Alonso A, Logroscino G, Hernan MA. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010;81:1249–52.
   PubMed Web of Science ®Google Scholar
• Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65:378–85.
   PubMed Web of Science ®Google Scholar
• Gallo V, Vanacore N, Bueno-de-Mesquita HB, Vermeulen R, Brayne C, Pearce N, et al. Physical activity and risk of amyotrophic lateral sclerosis in a prospective cohort study. Eur J Epidemiol. 2016;31:255–66.
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Madden C, Mays I, O’Sullivan M, et al. Measuring reliable change in cognition using the Edinburgh cognitive and behavioural ALS screen (ECAS). Amyotroph Lateral Scler Front Degener. 2018;19:65–73.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370–80.
   PubMed Web of Science ®Google Scholar
• Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Front Degener. 2015;16:172–9.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Turner MR. The reunification of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;90:141–47.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El Escorial “clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124:96–107.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Guidance. Motor neurone disease: assessment and management | Guidance and guidelines | NICE [Internet]. NICE guideline. NICE. 2016. Available at: https://www.nice.org.uk/guidance/ng42. Accessed October 22, 2016
   Google Scholar
• R Core Team. R: a language and environment for statistical computing. R foundation for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.
   Google Scholar
• Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, Abrahams S. Multidimensional apathy in ALS: validation of the dimensional apathy scale. J Neurol Neurosurg Psychiatry. 2016;87:663–9.
   PubMed Web of Science ®Google Scholar
• Henstridge CM, Sideris DI, Carroll E, Rotariu S, Salomonsson S, Tzioras M, et al. Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:213–26.
   PubMed Web of Science ®Google Scholar
• McGeachan AJ, Hobson EV, Al-Chalabi A, Stephenson J, Chandran S, Crawley F, et al. A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2017;18:1–9.
   PubMed Web of Science ®Google Scholar
• McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O’Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Comms. 2017;8:14774.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48:1043–8.
   PubMed Web of Science ®Google Scholar
• MND Scotland. Figures show “Aikman” impact on MND Care [Internet]. MND Scotland Website. 2018. Available at: https://www.mndscotland.org.uk/latest/news/figures-show-aikman-impact-on-mnd-care/. Accessed November 21, 2018.
   Google Scholar
• Longinetti E, Regodón Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi LO, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Front Degener. 2018;19:528–37.
   PubMed Web of Science ®Google Scholar
• Walker KL, Rodrigues MJ, Watson B, Reilly C, Scotter EL, Brunton H, et al. Establishment and 12-month progress of the New Zealand Motor Neurone Disease Registry. J Clin Neurosci. 2019;60:7–11.
   PubMed Web of Science ®Google Scholar